Španić Popovački, E.; Babić Leko, M.; Langer Horvat, L.; Brgić, K.; Vogrinc, Ž.; Boban, M.; Klepac, N.; Borovečki, F.; Šimić, G.
Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer’s Disease. Neurol. Int. 2023, 15, 842-856.
https://doi.org/10.3390/neurolint15030053
AMA Style
Španić Popovački E, Babić Leko M, Langer Horvat L, Brgić K, Vogrinc Ž, Boban M, Klepac N, Borovečki F, Šimić G.
Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer’s Disease. Neurology International. 2023; 15(3):842-856.
https://doi.org/10.3390/neurolint15030053
Chicago/Turabian Style
Španić Popovački, Ena, Mirjana Babić Leko, Lea Langer Horvat, Klara Brgić, Željka Vogrinc, Marina Boban, Nataša Klepac, Fran Borovečki, and Goran Šimić.
2023. "Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer’s Disease" Neurology International 15, no. 3: 842-856.
https://doi.org/10.3390/neurolint15030053
APA Style
Španić Popovački, E., Babić Leko, M., Langer Horvat, L., Brgić, K., Vogrinc, Ž., Boban, M., Klepac, N., Borovečki, F., & Šimić, G.
(2023). Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer’s Disease. Neurology International, 15(3), 842-856.
https://doi.org/10.3390/neurolint15030053